59 results
Page 2 of 3
8-K
EX-99.1
umn a3tf58c6
5 May 22
Axcella Reports First Quarter Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
dytpx 5wepu6ywjauc
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
424B5
wnb3sx
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
im2st0o vmpnwwg2j0
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-99.1
cgtcwtl1 7k7azxl
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
a6s3ppnv15sllv9
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-99.1
dxjs3z
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
oln7udzppatliyugqowc
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.1
bplhol4i5z4snyno 7n2
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.2
sczst 8a0ifma
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
si68o16
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
EX-99.1
4b5v6q9
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
d7nhg
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am